A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India - Concepedia

Concepedia

Publication | Open Access

A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India

DOI Full Paper Access

36

Citations

12

References

2021

Year

Prasad S. Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, Ashish Bavdekar, Madhu Gupta, Praveen Kulkarni, BS Garg, Nithya Gogtay, Muralidhar Tambe, Sanjay Lalwani,

EClinicalMedicine

References

	Year	Citations

Page 1